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Foodborne Campylobacter infections pose a serious threat to public health worldwide.
However, the occurrence and characteristics of Campylobacter in food animals and
products remain largely unknown in Tanzania. The objective of this study was to
determine the prevalence, antibiotic resistance, and genetic profiles (sequence types,
STs) of Campylobacter isolated from feces of pigs and dairy and beef cattle in Tanzania.
Overall, 259 (∼30%) of 864 samples were positive for Campylobacter spp, which
were detected in 32.5, 35.4, and 19.6% of the pig, dairy, and beef cattle samples,
respectively. Multiplex PCR analysis identified 64.5 and 29.3% of the Campylobacter
isolates as C. coli and C. jejuni, respectively. The majority (91.9%) of the isolates from pig
samples were identified as C. coli, while C. jejuni accounted for 65.5% of the isolates
from cattle. Antimicrobial susceptibility testing using the disk diffusion assay and the
broth microdilution method revealed resistance to: ampicillin (Amp) (70.3% and 75.7%,
respectively), gentamicin (Gen) (1.8% and 12.6%), streptomycin (Str) (65.8 and 74.8%),
erythromycin (Ery) (41.4 and 48.7%), tetracycline (Tet) (18.9 and 23.4%), and ciprofloxacin
(Cip) (14.4 and 7.2%). Resistance to nalidixic acid (Nal) (39.6%), azithromycin (Azm)
(13.5%), and chloramphenicol (Chl) (4.5%) was determined using the disk diffusion assay
only, while resistance to tylosin (Tyl) (38.7%) was quantified using the broth microdilution
method. Multilocus sequence typing of 111 Campylobacter isolates resulted in the
identification of 48 STs (26 C. jejuni and 22 C. coli) of which seven were novel (six C. jejuni
and oneC. coli). Taken together, this study revealed the high prevalence, genetic diversity
and antimicrobial resistance of Campylobacter in important food animals in Tanzania,
which highlights the urgent need for the surveillance and control of Campylobacter in
this country.
Keywords: Campylobacter, MLST, food animals, food safety, antimicrobial resistance
Kashoma et al. Antimicrobial resistance and genotyping of Campylobacter from Tanzania
INTRODUCTION
Campylobacter spp. are among the most common etiological
agents of foodborne bacterial gastroenteritis in humans
worldwide, accounting for an estimated 500 million infections
per year globally (Ruiz-Palacios, 2007; WHO, 2013). The number
of reported cases of campylobacteriosis is high in developed
countries (Scallan et al., 2011; EFSA and ECDC, 2014), while the
disease remains under reported in developing countries due to
the absence of regular surveillance programs (Coker et al., 2002).
In Tanzania, Campylobacter has been reported to affect up to
20% of children under 5 years old (Jacob et al., 2011; Deogratias
et al., 2014). Campylobacter is increasingly becoming a major
problem in Sub-Sahara Africa where the number of infections
is predicted to double by the year 2020 (Coker et al., 2002).
Furthermore, deficiencies in food safety regulations and limited
epidemiological data in many African countries, including
Tanzania, hamper the assessment, surveillance, and control of
Campylobacter infections. Therefore, in these countries, studies
that address the occurrence and antimicrobial resistance of
Campylobacter in food animals are of paramount importance.
Campylobacter is zoonotic and various food animals including
poultry, pigs, and cattle are implicated as important reservoirs
(Man, 2011; Sahin et al., 2015). Recent studies have shown that
the contributions of non-poultry associated Campylobacter to
human infections are considerable and warrant investigation
(Ragimbeau et al., 2008; Wilson et al., 2008). For example, it
was shown that cases of human Campylobacter infections can
be attributed equally to cattle and poultry sources in certain
countries (Wilson et al., 2008; de Haan et al., 2010). Studies
from different countries reported that Campylobacter prevalence
can range from 12 to 100% in dairy herds (Gilpin et al., 2008;
Ragimbeau et al., 2008; Pradhan et al., 2009; Sanad et al., 2011),
5.4 to 83% in beef cattle (Salihu et al., 2009; Haruna et al.,
2013), and 46 to 100% in pigs (Saenz et al., 2000; Pezzotti
et al., 2003; Payot et al., 2004; Litrup et al., 2007; Mdegela
et al., 2011). While Campylobacter jejuni can constitute the
predominant species isolated from cattle (Ragimbeau et al., 2008;
Sanad et al., 2011), Campylobacter coli is more frequently isolated
from pigs (Saenz et al., 2000; Mdegela et al., 2011). In addition
to potential contamination of milk and carcasses at slaughter,
Campylobacter colonization of cattle and pigs pose a serious
risk for contamination of surface and sub-surface water during
disposal of abattoir eﬄuents and animal slurries. This might
further contribute to the transmission of Campylobacter to other
food animals or directly to humans (Minihan et al., 2004; Devane
et al., 2005; Garrett et al., 2007). Consequently, defining the role
of cattle and pigs as reservoirs for these pathogens might be
important for understanding the epidemiology of Campylobacter
in Tanzania.
Most Campylobacter infections in humans are self-limiting
and do not require antimicrobial therapy. However, in systemic
infections or in immunocompromised individuals, erythromycin
(Ery) and fluoroquinolones are used as the drugs of choice.
However, studies have reported an increase in the resistance of
Campylobacter to various antimicrobials, including the drugs of
choice (Van Looveren et al., 2001; Chen et al., 2010; Cody et al.,
2010; Rozynek et al., 2010). The rise in antimicrobial resistant
Campylobacter has been linked to the use of antimicrobials in
veterinary medicine and in farming practices (White et al., 2002;
Zhu et al., 2006). While antimicrobial resistant Campylobacter
has been reported worldwide, the situation might be more
severe in developing countries where there is widespread and
largely uncontrolled use of antimicrobials (Byarugaba, 2004;
Kariuki, 2010). This is particularly important, because some of
the resistant isolates have been suspected to spread from food
animals to humans (Rozynek et al., 2010). Therefore, analysis
of antimicrobial resistance of Campylobacter isolated from food
animals in developing countries is needed to better manage
cognate infections and mitigate emergence of antimicrobial
resistant strains. Subsequently, in this study, we investigated
the prevalence, antimicrobial resistance, and genetic diversity of
Campylobacter isolated from pigs, dairy, and beef cattle from
three different geographical regions in Tanzania.
MATERIALS AND METHODS
Geographical Locations and Sample
Collection
A cross-sectional sampling was conducted between April 2013
and March 2014. Samples were collected from pigs, dairy, and
beef cattle from three geographically distinct regions of Tanzania,
namely Arusha in Northern Tanzania: Iringa in Southwestern
Tanzania, and Morogoro in Eastern Tanzania. These locations
were strategically selected, because they are among the regions
that hold the largest populations of farmed animals in Tanzania.
A total of 864 samples: pig feces (n = 458), beef cattle feces
(n = 214), and dairy cattle feces (n = 192) were collected from
the three regions [Arusha (n = 189; 82 pig, 47 dairy, and 60
beef samples), Iringa (n = 150; 66 pig, 32 dairy, and 52 beef
samples), and Morogoro (n = 525; 310 pig, 113 dairy, and 102
beef samples)]. Beef cattle feces samples (10 g) were randomly
and aseptically collected from the colon during slaughter at the
abattoirs. Similarly, 10 g of fresh pen-floor fecal samples were
aseptically collected from dairy cattle and pigs on farms. Samples
were placed on ice and immediately shipped to the laboratory
for Campylobacter isolation. All samples were processed within
24–48 h after collection.
Isolation of Campylobacter from Fecal
Samples
Campylobacter was isolated as described previously (Kashoma
et al., 2014, 2015). Approximately 2 g of feces were suspended
in 9mL of maximum recovery diluent (MRD) (Neogen, USA).
One milliliters of the suspension was added to 9mL of
Preston broth containing Campylobacter growth and selective
supplements (SR0117E and SR0232; Oxoid, England). The
suspensions were then incubated at 42◦C for 48 h in airtight
jars containing the Campy Pouch system (Becton Dickinson
and Co., Maryland, USA) to generate microaerobic conditions.
After incubation, 100µL of the suspension was spread onto a
modified charcoal cefoperazone deoxycholate agar (mCCDA)
plate (Oxoid) containing a Campylobacter selective supplement
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(SR0155E, Oxoid) and incubated for 48 h at 42◦C under
microaerobic conditions. Three to five colonies suspected
as Campylobacter were selected from each mCCDA plate
and further purified using Muller-Hinton (MH; Difco, MD)
agar plates containing a Campylobacter selective supplement
(SR0117E, Oxoid). Pure cultures were stored at −80◦C in MH
broth supplemented with 30% glycerol (vol/vol) until further
analysis.
Identification of Campylobacter Species
Using PCR
For PCR analysis, bacterial DNA lysates were prepared from
fresh pure Campylobacter cultures using the boiling method as
previously described (Kashoma et al., 2014, 2015). In cases where
no PCR products were detected, template DNA was prepared
using QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany)
according to the manufacturer’s instructions. Confirmation
and speciation of putative Campylobacter was performed by
multiplex-PCR (mPCR) as described previously (Linton et al.,
1997; Denis et al., 1999; Yamazaki-Matsune et al., 2007). Isolates
that were positive for the genus-specific PCR but negative for
the C. coli and C. jejuni-specific PCR were designated as other
thermophilic campylobacters (OTC). C. jejuni 81–176 (wild-type
strain) and C. coli (ATCC 33559) were used as positive controls,
while standard-grade laboratory water was used as a no template
(negative) control.
Antimicrobial Susceptibility Analysis
Antimicrobial resistance analysis was performed on 111
Campylobacter isolates (42 C. jejuni and 69 C. coli) that
were randomly selected to represent different animal hosts
and geographical locations. The antimicrobials tested are
representatives of the drugs used for humans and in the
animal industry in Tanzania (Kashoma et al., 2015; Komba
et al., 2015). The analysis was conducted using the Kirby-
Bauer disk diffusion and the broth microdilution methods
as described previously (Luber et al., 2003; Lehtopolku et al.,
2012; Kashoma et al., 2015). Both tests were performed
in accordance to the recommendations of the Clinical
Laboratory Standards Institute (CLSI, 2012). The results
were interpreted as susceptible, intermediately resistant, or
resistant according to the CLSI (2012) or the ROSCO MIC
for veterinary isolates (ROSCO, 2007) guidelines (Kashoma
et al., 2015). Multi-drug Resistance (MDR) was defined as
resistance to three or more antimicrobial agents (Hakanen et al.,
2003).
In the Kirby-Bauer disk diffusion test, nine antimicrobial
agents (Oxoid, UK) were tested at the following concentrations:
10µg ampicillin (Amp), 5µg ciprofloxacin (Cip), 15µg Ery,
30µg nalidixic acid (Nal), 10µg streptomycin (Str), 30µg
tetracycline (Tet), 15µg azithromycin (Azm), 10µg gentamicin
(Gen), and 30µg chloramphenicol (Chl). The antimicrobial discs
were placed on the surface of culture plates and the diameter of
the zone of inhibition was measured after 24 h of microaerobic
incubation at 42◦C.
For the broth microdilution test and the determination of
the minimum inhibitory concentration (MIC), 96-well plates
containing two-fold serial dilutions of the antimicrobial agents
were used as described previously (Ge et al., 2013; Kashoma
et al., 2015). The antimicrobial agents tested included Amp,
Cip, Ery, Gen, tylosin (Tyl), Str, and Tet. MIC values were
defined as the lowest concentration of an antimicrobial agent
that produced no visible growth and the results were confirmed
spectrophotometrically using a microplate reader (Multiskan R©
Spectrum, Thermo Scientific, USA) (Ge et al., 2013). In both
assays, C. jejuni 81–176 and C. coli (ATCC 33559) were used as
positive control strains.
Multilocus Sequence Typing (MLST)
Analysis
In order to determine the genetic diversity of the Campylobacter
isolates and their relationship to existing clonal complexes (CC)
and sequence types (STs), 111 isolates (42 C. jejuni and 69 C.
coli) which were also tested for antimicrobial resistance were
analyzed by MLST as described previously (Dingle et al., 2001;
Sanad et al., 2011). Briefly, loci from seven housekeeping genes
(aspA, glnA, gltA, glyA, pgm, tkt, and uncA) were amplified using
PCR and specific primers (Dingle et al., 2001). The size of the
amplicons was confirmed using agarose gel electrophoresis. PCR
products were then treated with ExoSAP (Affymetrix Inc., USA),
sequenced in both directions. The forward and reverse sequences
were aligned using ClustalW (www.ebi.ac.uk/clustalw), allele
profiles were determined by BLAST analysis using the single-
locus query function, while STs were assigned using the allele
profile query function available in the MLST Campylobacter
database (http://pubmlst.org/campylobacter). STs were then
traced to their respective CC using BURST (http://pubmlst.
org/).
Statistical Analysis
The prevalence and antimicrobial resistance of Campylobacter
from pigs, dairy, and beef cattle in all three regions were
compared using the Chi-squared (χ2) test. A value of P <
0.05 was considered statistically significant. Agreement between
the two antimicrobial resistance tests was determined using the
Kappa statistic (Luber et al., 2003). A Kappa value of 100%
indicates total agreement between the classifiers.
RESULTS
The Prevalence of Campylobacter in Feces
Sampled from Cattle and Pigs
Campylobacter were detected in 259 (30%) of 864 fecal samples
and were distributed as follows: a total of 149 (32.5%), 68 (35.4%),
and 42 (19.6%) isolates were retrieved from pig, dairy, and beef
cattle fecal samples, respectively. C. jejuni and C. coli constituted
the majority of the isolates and were detected in 76 (8.8%) and
166 (19.3%) of the samples, respectively (Table 1). There was
no significant difference (P > 0.05) in the total number of C.
jejuni isolated from fecal samples obtained from either dairy
(21.9%) or the beef cattle (14.0%). Significantly (P < 0.0001)
more C. coli were isolated from pigs (29.9%) in comparison to
cattle (7.4%), whileC. jejuniwas significantly higher (P < 0.0001)
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TABLE 1 | The prevalence of Campylobacter species in pig, dairy, and beef cattle feces collected from three geographical locations in Tanzania.
Region Sources Prevalence (%); positive samples/No. of samples tested Positive samples No. %
C. jejuni C. coli C. jejuni/C. colia OTCb
Arusha Pig 36.6% (30/82) 2 (2.4%) 25 (30.5%) 1 (1.2%) 2 (2.4%)
Dairy 29.8% (14/47) 7 (14.9%) 6 (12.8%) – 1 (2.1%)
Beef 13.3% (8/60) 6 (10.0%) 1 (1.7%) – 1 (1.7%)
Iringa Pig 22.7% (15/66) – 13 (19.7%) 1 (1.5%) 1 (1.5%)
Dairy 25.0% (8/32) 5 (15.6%) 2 (6.3%) – 1 (3.1%)
Beef 9.6% (5/52) 4 (7.7%) 1 (1.9%) – –
Morogoro Pig 33.6% (104/310) 2 (0.7%) 99 (31.9%) 1 (0.3%) 2 (0.7%)
Dairy 40.7% (46/113) 30 (26.6%) 14 (12.4%) 1 (0.9%) 1 (0.9%)
Beef 27.5% (29/102) 20 (19.6%) 6 (5.9%) 1 (1.0%) 2 (1.9%)
Total 29.98% (259/864) 76 (8.8%) 167 (19.2%) 5 (0.6%) 11 (1.3%)
a Isolates that were positive for both C. jejuni and C. coli.
bOTC, other thermophilic Campylobacter species.
in cattle (17.7%) than in pig (0.9%) samples. Furthermore, the
occurrence of Campylobacter in animals varied according to
geographic location of sampling sites. Specifically,Campylobacter
were retrieved from 34.1% of all fecal samples collected from
Morogoro, which was significantly higher (P < 0.05) than those
from Arusha (27.5%) and Iringa (18.7%), respectively (Table 1).
Moreover, total C. coli prevalence was significantly higher (P <
0.05) inMorogoro (5.9%) than in Arusha (1.7%) or Iringa (1.9%).
The combined prevalence of C. jejuni in beef and dairy cattle
feces from Morogoro (23.2%; 50 C. jejuni retrieved from 215
fecal samples) was significantly higher (P < 0.05) in comparison
to that from Arusha (12.2%) and Iringa (10.7%), respectively.
However, no significant difference (P > 0.05) in the prevalence
of C. jejuni in beef and dairy cattle feces was observed between
Arusha and Iringa.
Antimicrobial Susceptibility of the C. jejuni
and C. coli Isolates
Analysis of the Kirby-Bauer disk diffusion assay showed that
106 of the 111 isolates (95.5%) were resistant to one or more
antimicrobial agents, whereas five (4.5%) isolates were pan-
susceptible to all antimicrobials tested (Table 2). Twenty-one
isolates (18.9%; six C. jejuni and 15 C. coli) were resistant to a
single antimicrobial agent and 22 isolates (19.8%; 10 C. jejuni
and 12 C. coli) showed resistance to two antimicrobial agents
(Table 2). Sixty-three (56.8%) of all isolates (24 C. jejuni and
39 C. coli) were classified as MDR. Of the MDR isolates, 38
(60.3%) were from pig, 15 (23.8%) from dairy, and 10 (15.9%)
from beef cattle feces. Two C. jejuni isolates recovered from
dairy cattle were resistant to Gen, whereas 9.0% of all isolates
(four C. jejuni and six C. coli) were resistant to Chl (Table 2).
Approximately 14.4% (six C. jejuni and 10 C. coli) and 13.5% (six
C. jejuni and nine C. coli) of the isolates were resistant to Cip
and Azm, respectively (Tables 2, 4). Twenty-one (18.9%) isolates
were shown to be resistant to Tet, 46 (41.4%) to Ery, and 44
(39.6%) to Nal. In addition, 65.8% (34 C. jejuni and 39 C. coli)
and 70.3% (28 C. jejuni and 50 C. coli) of isolates were resistant
to Str and Amp, respectively (Tables 2, 4). While resistance to Str
was significantly higher (P < 0.05) in isolates recovered from
cattle in comparison to those from pigs, there were no significant
differences (P > 0.05) in resistance associated with the remaining
antimicrobials.
The analysis of antimicrobial resistance by the broth
microdilution method revealed that the majority (94.6%)
were resistant to at least one antimicrobial agent, while six
(5.4%) isolates were pan-susceptible. The Campylobacter isolates
displayed resistance most frequently to Amp (75.7%) and less
frequently to Cip (7.2%) (Tables 3, 4). In comparison to C.
jejuni, significantly more (P < 0.05) C. coli isolates displayed
resistance to Str and Amp regardless of the source of the isolates.
Seventeen of 42 C. jejuni (40.5%) isolates were resistant to three
or more antimicrobials, while, 69.6% (48/69) of C. coli isolates
were resistant to three or more antimicrobials. Approximately
2.4 and 28.6% of C. jejuni isolates were resistant to Cip and
Gen, respectively (Table 3). Additionally, 10.2% and 2.9% of C.
coli strains were resistant to Cip and Gen, respectively. While
the number of C. coli isolates resistant to Gen was significantly
different (P < 0.01) in comparison to that of C. jejuni, there
was no significant difference with respect to resistance to Cip.
The number of C. jejuni (42.9%) isolates resistant to Tyl was not
significantly different in comparison to that of C. coli (36.2%)
(P > 0.05). However, the number of C. jejuni (19.1%) isolates
resistant to Ery was significantly different in comparison to that
of C. coli (66.7%) (P < 0.0007).
Using the broth microdilution and disk diffusion methods,
similar results (P > 0.05) were obtained for five out of six
antimicrobial agents (Cip, Str, Amp, Ery, Tet) tested (Table 4).
The correlation coefficients between the results obtained from
the two methods were 0.0043 for Gen, 0.3596 for Cip, 0.4196
for Ery, 0.5671 for Str, 0.8566 for Tet, and 0.7390 for Amp.
Additionally analysis using the Kappa statistics showed that
the results obtained using the two tests were mostly in
high agreement. The Kappa values were 0.739 for Cip, 0.695
for Ery, 0.898 for Str, 0.977 for Amp, and 0.999 for Tet.
Lower agreement was only found for Gen (Kappa = 0.226)
(Table 4).
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TABLE 2 | Antimicrobial resistance of C. jejuni and C. coli isolated from pig, dairy, and beef cattle samples.
Resistance profilea Resistant isolates Source of isolate and number of resistant isolates (%)
Pig Dairy cattle Beef cattle
No. (%) C. jejuni
(n = 42)
C. coli
(n = 69)
C. jejuni
(n = 2)
C. coli
(n = 67)
C. jejuni
(n = 26)
C. coli
(n = 1)
C. jejuni
(n = 14)
C. coli
(n = 1)
Pan-susceptible 5 (4.5) 2(4.8) 3(4.4) 0 3 (4.5) 2 (7.7) 0 0 0
Amp 12 (10.8) 2(4.8) 10(14.5) 0 10 (14.9) 1 (3.9) 0 1 (7.1) 0
Ery 2 (1.8) 0 2(2.9) 0 2 (3.0) 0 0 0 0
Str 4 (3.6) 1(2.4) 3(4.4) 0 3 (4.5) 0 0 1 (7.1) 0
Nal 3 (2.7) 3(7.2) 0 0 0 2 (7.7) 0 1 (7.1) 0
Amp/Cip 1 (0.9) 0 1(1.5) 0 1 (1.5) 0 0 0 0
Str/Tet 3 (2.7) 1(2.4) 2(2.9) 0 2 (3.0) 1 (3.9) 0 0 0
Azm/Ery 2 (1.8) 0 2(2.9) 0 2 (3.0) 0 0 0 0
Amp/Str 11 (9.9) 7(16.7) 4(5.8) 1 (50.0) 4 (6.0) 4 (15.4) 0 2 (14.3) 0
Nal/Str 2 (1.8) 1(2.4) 1(1.5) 0 1 (1.5) 1 (3.9) 0 0 0
Amp/Ery 3 (2.7) 1(2.4) 2(2.9) 0 2 (3.0) 1 (3.9) 0 0 0
Amp/Ery/Str 7 (6.3) 3(7.2) 4(4.8) 0 4 (6.0) 1 (3.9) 0 2 (14.3) 0
Ery/Nal/Tet 2 (1.8) 0 2(2.9) 0 2 (3.0) 0 0 0 0
Amp/Nal/Str 6 (5.4) 3(7.2) 3(4.4) 0 3 (4.5) 2 (7.7) 0 1 (7.1) 0
Cip/Ery/Str 2 (1.8) 1(2.4) 1(1.5) 0 1 (1.5) 1 (3.9) 0 0 0
Amp/Nal/Str 3 (2.7) 2(4.8) 1(1.5) 1 (50.0) 1 (1.5) 1 (3.9) 0 0 0
Amp/Tet/Str 6 (5.4) 1(2.4) 5(7.3) 0 4 (6.0) 1 (3.9) 1 (100) 0 0
Azm/Ery/Str 2 (1.8) 0 2(2.9) 0 2 (3.0) 0 0 0 0
Amp/Ery/Nal/Str 9 (8.1) 4(9.5) 5(7.3) 0 5 (7.5) 2 (7.7) 0 2 (14.3) 0
Amp/Ery/Chl/Str 4 (3.6) 1(2.4) 3(4.4) 0 3 (4.5) 0 0 1 (7.1) 0
Amp/Nal/Str/Tet 2 (1.8) 0 2(2.9) 0 2 (3.0) 0 0 0 0
Cip/Azm/Chl/Nal 5 (4.5) 3(7.2) 2(2.9) 0 2 (3.0) 2 (7.7) 0 1 (7.1) 0
Amp/Ery/Gen/Str 2 (1.8) 2(4.8) 0 0 0 2 (7.7) 0 0 0
Cip/Amp/Ery/Nal/Tet 3 (2.7) 0 3(4.4) 0 3 (4.5) 0 0 0 0
Amp/Azm/Ery/Nal/Str 4 (3.6) 2(4.8) 2(2.9) 0 1 (1.5) 0 0 2 (14.3) 1 (100)
Amp/Chl/Ery/Nal/Str 1 (0.9) 0 1(1.5) 0 1 (1.5) 0 0 0 0
Cip/Amp/Ery/Nal/Str/Tet 3 (2.7) 1(2.4) 2(2.9) 0 2 (3.0) 1 (3.9) 0 0 0
Cip/Amp/Azm/Ery/Nal/Str 1 (0.9) 1(2.4) 0 0 0 1 (3.9) 0 0 0
Cip/Amp/Azm/Ery/Nal/Str/Tet 1 (0.9) 0 1(1.5) 0 1 (1.5) 0 0 0 0
The antimicrobial resistance was determined using the disk diffusion method. Results are shown as number of isolates with percentage given in parentheses.
aAmp, ampicillin; Azm, azithromycin; Chl, chloramphenicol; Cip, ciprofloxacin; Ery, erythromycin; Gen, gentamicin; Nal, nalidixic acid; Str, streptomycin; Tet, tetracycline.
MLST Analysis of C. jejuni and C. coli
Isolates
MLST was performed to determine the genetic diversity and
clonal origins of the Campylobacter isolates that were tested
for antimicrobial resistance. A total of 48 different STs were
identified for the 111 Campylobacter isolates. The C. jejuni
isolates (n = 42) were classified into 26 unique STs of which six
(STs 7690, 7697, 7698, 7699, 7700, and 7701) were novel. These
novel STs were distributed as follows: three were identified from
dairy cattle, two from beef, and one ST from pigs. Nineteen C.
jejuni STs were assigned to a previously described clonal complex
(CC 828), whereas seven STs (including the six new STs) belonged
to an undefined clonal complex (Table 5). The C. coli isolates
(n = 69) were classified into 22 STs (Table 5). Two C. coli isolates
were assigned to a new ST (ST 7683). Fifty two C. coli isolates
(18 STs) were assigned to a previously described clonal complex
(CC 828), while 17 isolates (four STs) belonged to an undefined
clonal complex. Overall, these findings imply the occurrence of
diverse strains, with majority of STs appearing to not overlap
between sources and geographical locations. Only the C. coli ST
2713 was identified in two geographical locations (Arusha and
Iringa), whereas ST 4309 occurred in pig and dairy samples.
Association of Sequence Types (STs) with
Antimicrobial Resistance Pattern
The majority of C. jejuni STs (21 STs; 37 isolates) were resistant
to multiple antimicrobials, whereas two STs (ST 2139 and ST
2878) were susceptible to all antimicrobials tested by the broth
microdilution method (Table 5). Almost all the C. jejuni isolates
that belonged to undefined CCwere resistant to either one or two
antimicrobials. In general, C. coli isolates showed more diverse
antimicrobial resistance profiles in comparison to C. jejuni
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TABLE 3 | Antimicrobial resistance of C. jejuni and C. coli isolated from pig, dairy, and beef cattle samples.
Resistance profilea Resistant isolates Source of isolate and number of resistant isolates (%)
Pig Dairy cattle Beef cattle
Number (%) C. jejuni
(n = 42)
C. coli
(n = 69)
C. jejuni
(n = 2)
C. coli
(n = 67)
C. jejuni
(n = 26)
C. coli
(n = 1)
C. jejuni
(n = 14)
C. coli
(n = 1)
Pan-susceptible 6 (5.4) 6(14.3) 0 0 0 3 (11.5) 0 3 (21.4) 0
Gen 1 (0.9) 1(2.4) 0 0 0 1 (3.9) 0 0 0
Ery 1 (0.9) 1(2.4) 0 0 0 0 0 1 (7.1) 0
Str 2 (1.8) 2(4.8) 0 0 0 0 0 2 (14.3) 0
Gen/Str 2 (1.8) 2(4.8) 0 0 0 2 (7.7) 0 0 0
Gen/Tyl 1 (0.9) 1(2.4) 0 0 0 1 (3.9) 0 0 0
Amp/Tyl 4 (3.6) 4(9.5) 0 0 0 1 (3.9) 0 3 (21.4) 0
Ery/Str 5 (4.5) 2(4.8) 3(4.4) 0 3 (4.8) 1 (3.9) 0 1 (7.1) 0
Amp/Tet 3 (2.7) 1(2.4) 2(2.9) 0 2 (3.0) 0 0 1 (7.1) 0
Str/Tyl 2 (1.8) 1(2.4) 1(1.5) 0 1 (1.5) 1 (3.9) 0 0 0
Cip/Tyl 1 (0.9) 1(2.4) 0 0 0 1 (3.9) 0 0 0
Tet/Str 2 (1.8) 2(4.8) 0 0 0 2 (7.7) 0 0 0
Amp/Str 11 (9.9) 2(4.8) 9(13.0) 2 (100.0) 9 (13.4) 0 0 0 0
Amp/Ery 5 (4.5) 0 5(7.3) 0 5 (7.5) 0 0 0 0
Gen/Amp/Tyl 3 (2.7) 3(7.1) 0 0 0 1 (3.9) 0 2 (14.3) 0
Amp/Str/Tyl 7 (6.3) 3(7.1) 4(5.8) 0 4 (6.0) 2 (7.7) 0 1 (7.1) 0
Ery/Str/Tyl 2 (1.8) 1(2.4) 1(1.5) 0 0 1 (3.9) 0 0 1 (100)
Amp/Ery/Str 15 (13.5) 4(9.5) 11(15.9) 0 11 (16.4) 4 (15.4) 0 0 0
Gen/Amp/Str 2 (1.8) 1(2.4) 1(1.5) 0 1 (1.5) 1 (3.9) 0 0 0
Amp/Tyl/Tet 3 (2.7) 0 3(4.4) 0 3 (4.8) 0 0 0 0
Amp/Str/Tet 2 (1.8) 0 2(2.9) 0 2 (3.0) 0 0 0 0
Gen/Amp/Str/Tyl 3 (2.7) 3(7.1) 0 0 0 3 (11.5) 0 0 0
Amp/Ery/Str/Tyl 12 (10.8) 0 12(17.4) 0 12 (17.9) 0 0 0 0
Cip/Amp/Ery/Str 4 (3.6) 0 4(5.8) 0 4 (6.0) 0 0 0 0
Amp/Ery/Str/Tet 4 (3.6) 0 4(5.8) 0 3 (4.8) 0 1 (100) 0 0
Ery/Str/Tet/Tyl 2 (1.8) 0 2(2.9) 0 2 (3.0) 0 0 0 0
Amp/Ery/Str/Tet/Tyl 1 (0.9) 0 1(1.5) 0 1 (1.5) 0 0 0 0
Cip/Amp/Ery/Str/Tet 3 (92.7) 0 3(4.4) 0 3 (4.8) 0 0 0 0
Gen/Amp/Str/Tet/Tyl 2 (1.8) 1(2.4) 1(1.5) 0 1 (1.5) 1 (3.9) 0 0 0
The antimicrobial resistance was determined using the broth microdilution method. Results are shown as number of isolates with percentage given in parentheses.
aAmp, ampicillin; Cip, ciprofloxacin; Ery, erythromycin; Gen, gentamicin; Str, streptomycin; Tet, tetracycline; Tyl, tylosin.
isolates (Table 5). With the exception of ST 2814, which was
represented by one isolate that was resistant to two antimicrobial
agents, the majority of STs included isolates with different
resistance profiles despite belonging to the same ST (Table 5).
Mostly, C. coli STs were significantly associated with MDR (P <
0.05) with the majority (86.7%) of isolates in the undefined
complex being resistant to three or more antimicrobials.
DISCUSSION
We assessed the prevalence, antimicrobial resistance and genetic
diversity of Campylobacter isolated from pigs, dairy, and beef
cattle in Tanzania, where animal husbandry is a very important
agricultural activity (MLDF, 2014). In this study, the prevalence
of Campylobacter in dairy and beef cattle samples was similar
to the findings reported in other countries (Gilpin et al., 2008;
Ragimbeau et al., 2008; Pradhan et al., 2009; Salihu et al., 2009;
Sanad et al., 2011). Furthermore, the overall recovery rate of
Campylobacter from cattle was significantly different among
the three sampling location/regions. While the prevalence of
C. coli in the pig samples in this study was in agreement
with previous reports (Saenz et al., 2000; Jensen et al., 2006),
it was also slightly lower than those reported in many other
studies (Saenz et al., 2000; Pezzotti et al., 2003; Payot et al.,
2004; Mdegela et al., 2011). The differences in C. jejuni and/or
C. coli prevalence within Tanzania and between countries may
be due to several factors, including farming and slaughtering
practices, geographical locations, or other risk factors, including
the concentration of the farms in each location and their
proximity to other livestock such as poultry (Moore et al., 2002;
Humphrey et al., 2007; Sahin et al., 2015).
Both the agar disk diffusion and the broth microdilution
methods have commonly been used to determine antimicrobial
resistance in Campylobacter (Miflin et al., 2007; Senok et al.,
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TABLE 4 | Comparison of antimicrobial resistance of Campylobacter spp. identified by disk diffusion and broth microdilution methods.
Antimicrobial agent Disk diffusion Broth microdilution Agreement between methods
No. of isolates % of resistant isolates No. of isolates % of resistant isolates
S I R S I R Correlation coefficient Kappa values
AMINOGLYCOSIDES
Gentamicin 65 44 2 1.80% 54 43 14 12.61% 0.0043 0.226
Streptomycin 9 29 73 65.77% 7 21 83 74.77% 0.5671 0.898
β- LACTAM
Ampicillin 13 20 78 70.27% 10 17 84 75.68% 0.7390 0.997
MACROLIDES
Azithromycin 48 48 15 13.51% – – – – – –
Erythromycin 27 38 46 41.44% 28 29 54 48.65% 0.4196 0.695
Tylosin – – – – 7 61 43 38.74% – –
QUINOLONES
Ciprofloxacin 62 33 16 14.41% 78 25 8 7.21% 0.3596 0.739
Nalidixic acid 40 27 44 39.64% – – – – – –
PHENICOL
Chloromphenicol 77 29 5 4.50% – – – – – –
TETRACYCLINE
Tetracycline 48 42 21 18.92% 33 56 22 19.82% 0.8566 0.999
S, susceptible; I, intermediate; R, resistance. MIC and zone of inhibition breakpoints are listed in Kashoma et al. (2015).
2007). Because of the importance of the implications associated
with reporting antimicrobial resistance in human food-borne
pathogens, in this study two methods were used in order to
generate robust analysis and reduce methodological bias. Our
results showed an agreement between these two methods for
most of the antimicrobials tested (Table 4), suggesting that
either method was generally adequate for analyzing antimicrobial
resistance. However, in certain cases such as Gen where
the agreement between the two methods was low, multiple
susceptibility testing approaches must be adopted and results
must be interpreted cautiously to account for methodological
variability. The comparison between the two methods is also
particularly important for facilitating research conducted in
resource limited countries like Tanzania, because it allows the
selection of a suitable method for antimicrobial resistance
analysis without unnecessary expenditures.
A considerable number of Campylobacter isolates in this study
was resistant to macrolides (Ery, Tyl, and Azm) (Tables 2, 3).
Macrolides such as Tyl are extensively used in Tanzania as
therapeutic agents for treatment of cattle respiratory conditions
(Kashoma et al., 2015). The use of Tyl in animals for the
purpose of either treatment or growth promotion contributes
to the selection of resistant Campylobacter strains to macrolides
including Ery (Juntunen et al., 2010). These observations suggest
a possible association between the heavy use of Tyl in Tanzania
and the increase in the resistance Campylobacter to Tyl and
Ery observed in this study. Furthermore, the high resistance
to macrolides (Ery) in Campylobacter isolated from humans
in Tanzania (Komba et al., 2015) highlights the need for
understanding the impact of the use of antimicrobials in animal
agriculture on the rise of resistant pathogens in food animals and
humans. This further emphasizes the need for Campylobacter
surveillance and control studies in Tanzania.
In this study, a relatively high level of resistance to Nal (47.6%
C. jejuni and 34.8% C. coli) was observed, while the number of
Cip resistant Campylobacter isolates (11.7% and 7.2% using the
disk diffusion and broth microdilution methods, respectively)
was relatively low (Tables 2, 4). The wide-spread resistance to
Nal corroborated reports on Campylobacter from different food
animals/products in other countries (Taremi et al., 2006; Bostan
et al., 2009; Dabiri et al., 2014), while Cip resistance was generally
lower than elsewhere (Taremi et al., 2006; Wieczorek and Osek,
2013). Furthermore, in a previous study on beef carcasses and
raw milk in Tanzania (Kashoma et al., 2015), it was observed
that C. jejuni (65.7%) and C. coli (63.2%) isolates were resistant
to Nal, while 9.3–11.8% were resistant to Cip. The resistance
to Cip in isolates originating from food animals/products in
Tanzania is of concern, because this antimicrobial is used for
treatment of human campylobacteriosis. Currently, the factors
that are promoting Cip resistance in Tanzanian food-associated
isolates are not clear, especially because it is known that this
antimicrobial is not commonly used in animal agriculture in
Tanzania. However, enrofloxacin is licensed for therapeutic use in
poultry against colibacilliosis, pasteurellosis, and mycoplasmosis
(Mubito et al., 2014), which may result in the selection of
resistance of Campylobacter to fluoroquinolones. These resistant
isolates might be transmitted to other food animals that are in the
proximity of poultry via a variety of vehicles, including common
farm workers and/or flies or other critters (McDermott et al.,
2002; Van Boven et al., 2003; Stapleton et al., 2010). Furthermore,
it is possible that Cip resistant isolates might have originated
from humans where this antimicrobial is commonly used. This
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TABLE 5 | Distribution of clonal complexes, sequence types and antimicrobial resistance profiles (Broth microdilution assay) of C. jejuni and C. coli from
pig, dairy, and beef cattle in Tanzania.
ST-CC ST No. of isolates Source Geographical location Resistance profilesa
Campylobacter jejuni
828 899 3 Dairy Morogoro GenStr, CipTyl, GenTylStr
1016 1 Dairy Morogoro AmpGenTylstr
1145 3 Dairy Arusha AmpEryStr, EryTylStr, AmpGenEryStr
1201 1 Dairy Morogoro Gen
1465 1 Beef Arusha GenTylStr
1563 4 Dairy Morogoro Pan, TylTet, AmpTylStr, AmpEryStr
1635 2 Dairy Morogoro AmpEryTet, AmpEryStr
1837 2 Beef Morogoro Str, EryTet,
1987 1 Beef Morogoro AmpTyl
2139 1 Beef Morogoro Pan
2702 1 Beef Morogoro EryStr
2878 1 Beef Iringa Pan
4083 1 Dairy Morogoro AmpTylStr
4085 3 Dairy Morogoro Pan, StyTet, AmpGenStr
4679 1 Dairy Morogoro AmpGenStr
7033 1 Beef Arusha Str
UC 1240 2 Beef Morogoro Pan, TylStrTet
4609 1 Dairy Morogoro GenStr
7031 1 Beef Morogoro AmpTyl
7690 2 Pig Arusha AmpStr
7697 2 Dairy Morogoro Pan, StrTyl
7698 2 Beef Arusha Ery, AmpGenTyl
7699 1 Dairy Arusha EryTyl
7700 3 Dairy Arusha CipTyl, StrTet, AmpGenTet
7701 1 Beef Morogoro AmpTyl
Campylobacter coli
828 872 2 Pig Iringa CipEryTylStrTet, EryTylStrTet
890 3 Pig Morogoro AmpEryTylStrTet, CipEryTylStrTet, AmpEryTyrStr
1056 2 Pig Morogoro CipTylStr, AmpEryTylStr
1117 2 Pig Iringa EryStr, AmpEryStrTet
1153 4 Pig Morogoro AmpStr, AmpEryStr, AmpEryStrTyl
1417 2 Pig Morogoro AmpEry, AmpEryStrTyl
1432 2 Pig Iringa AmpStrTyl, AmpTetTyl
1549 1 Beef Morogoro EryStrTyl
1628 2 Pig Morogoro AmpStrTyl, AmpEryStrTyl
1946 2 Pig Arusha AmpTet, AmpStr
2507 6 Pig Morogoro AmpStr, EryStr, StrTyl, AmpEryTyl, AmpEryTetTyl
2713 4 Pig Morogoro AmpStr, AmpTyl, AmpStrTet
2814 1 Pig Morogoro AmpTet
4085 1 Pig Morogoro AmpEryStrTyy
4309 4 Pig; Dairy Morogoro AmpEry, AmpStr, AmpEryStrTet, AmpStrTetTyl
5250 5 Pig Morogoro, Arusha AmpStr, AmpEryTyl, AmpEryStr, AmpEryStrTyl
5305 2 Pig Iringa AmpStrTyl, AmpEryTyl
5345 7 Pig Morogoro EryStr, CipAmp, AmpEryStrTet, AmpEryStrTyl, AmpEryStr, CipAmpEryStr
UC 1469 3 Pig Arusha AmpEry, AmpStrTet, AmpEryStrTyl
1470 4 Pig Arusha AmpEryStr, AmpTetTyl,
6823 8 Pig Morogoro AmpEry, AmpEryGen, AmpStrTyl, AmpGenStrTyl, AmpEryStr, AmpEryStrTyl,
CipAmpEryStrTet, CipAmpEryStrTet
7683 2 Pig Iringa AmpEryStr
UC, undefined clonal complex.
aAmp, Ampicillin; Cip, Ciprofloxacin; Ery, Erythromycin; Gen, Gentamicin; Tet, Tetracycline; Str, Streptomycin; Tyl, tylosin; Pan, Pan-susceptible.
Each antimicrobial resistance profile is underlined.
Bolded numbers show new STs deposited to Pubmlst database.
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might be supported by a recent report showing that a relatively
high percentage (22.1%) of human Campylobacter isolates were
resistant to Cip in Tanzania (Komba et al., 2015). Regardless, the
determination of factors that select for Cip resistant isolates will
require further investigation.
In this study, a range of resistance (low to high number of
isolates) was observed for different antimicrobials. Specifically, a
relatively low number of isolates were resistant to Gen (1.8–12.6%
of isolates depending on the testing method) and Chl (6.3%),
respectively. Generally, Chl and Gen resistance in Campylobacter
is known to be low (Fallon et al., 2003; Kassa et al., 2007).
Furthermore, a previous study in Tanzania showed that 13% and
11.8% of the Campylobacter isolated from beef carcasses and raw
milk were resistant to Chl and Gen, respectively (Kashoma et al.,
2015). Since Tets are widely used in humans and as therapeutics
or feed additives in livestock and poultry in Tanzania, a high
number of Tet resistant isolates was expected. For example,
Komba et al. (2015) reported 76.5% and 57.1% of human-
associated C. jejuni and C. coli were resistant to Tet in Tanzania.
However, a moderate resistance to Tet (19.8% of the isolates)
was observed in this study. The reasons behind this are currently
not clear and require further analysis. In contrast, Campylobacter
can inherently display resistance to β-lactams (including Amp)
(Engberg et al., 2006; Li et al., 2007). Consequently, the
high resistance to Amp observed in this study was not
surprising.
In recent yearsmultidrug resistantCampylobacter strains have
been increasingly reported worldwide, which is now recognized
as a major emerging public health concern. The numbers of
multidrug resistant isolates (40% C. jejuni and 69.9% C. coli) are
comparable to those reported in other countries (Van Looveren
et al., 2001; Pezzotti et al., 2003; Wieczorek and Osek, 2013).
Furthermore, analysis of human-associated Campylobacter in
Tanzania showed that 77.9% of the isolates were resistant to more
than six of the tested antimicrobials, while 19.9% were resistant
to all tested antimicrobials (n = 12) (Komba et al., 2015). While
the contribution of food animal-associated isolates to the MDR
in human isolates is currently unknown, this is a point of serious
concern that suggests that Tanzania, like other countries, has to
devise stringent control and regulatory measures to reduce MDR
isolates in the food chain.
MLST analysis classified the tested isolates into 48 STs. Almost
71.2% of the isolates were assigned to known CC, while 28.8%
could not be traced to known lineages. These findings highlight
the diversity of Campylobacter genotypes and suggest that certain
food-animal associated isolates might have evolved and adapted
to Tanzanian farm animals and/or farming practices. In this
study, the majority of C. coli and C. jejuni isolates belonged to
ST 828 clonal complex, which is associated mainly with isolates
from agricultural and environmental sources and human clinical
cases (Sheppard et al., 2010). Also, researchers have reported the
presence of progenitor strains of the ST 828 complex in human,
swine, poultry, and cattle from different parts of the world
(Dingle et al., 2005;Miller et al., 2006; Sanad et al., 2011; Kashoma
et al., 2014). This is important, because the contributions of
various possible sources of infection, including food animals,
to the burden of human campylobacteriosis in Tanzania is not
clearly defined and require further investigations.
CONCLUSIONS
In the present study, a high prevalence and genotypic diversity
of Campylobacter from pigs, dairy, and beef cattle in Tanzania
was observed. The majority of the Campylobacter isolates
examined were resistant to multiple antimicrobials, which was
confirmed using two different methods Therefore, prudent use of
antimicrobials in veterinary/farming practices remains essential
to reduce the pool of antimicrobial resistant pathogens thatmight
impact human health. Collectively, this study highlights the need
for continuous efforts to control Campylobacter colonization
in farm animals in order to limit the transmission of these
pathogens to humans.
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